Total medical costs of $16K for IFN-based antiviral tx for HCV

March 24, 2016

(HealthDay)—The total medical costs associated with interferon (IFN)-based antiviral treatment among patients with chronic hepatitis C virus (HCV) infection average €14,559, with a mean cost of €38,514 per sustained virological response (SVR), according to a study published online March 18 in the Journal of Gastroenterology and Hepatology.

Raoel Maan, M.D., from the Erasmus MC University Medical Center in Rotterdam, Netherlands, and colleagues conducted a to examine the direct medical costs during IFN-based antiviral treatment and costs per SVR among with chronic HCV infection and biopsy-proven bridging fibrosis or cirrhosis. The study included 672 IFN-based treatments administered to 455 patients in five hepatology units of tertiary care centers in Europe and Canada.

The researchers found that the average total per patient were €14,559; with a mean cost per SVR of €38,514. Per SVR, the mean costs were €26,105 for patients with a normal platelet count, €50,907 for patients with thrombocytopenia, and €74,961 for patients with a platelet count below 100×109/L.

"Due to the lower SVR rates, the cost per SVR of IFN-based treatment increased when patients with more advanced liver disease were treated," the authors write. "Additional costs of IFN-free therapy could be limited among these patients."

Several authors disclosed financial ties to the pharmaceutical industry, including GlaxoSmithKline, which funded the study.

Explore further: AFP levels predict fibrosis regression after SVR in hep C

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

AFP levels predict fibrosis regression after SVR in hep C

December 7, 2015
(HealthDay)—For patients with chronic hepatitis C virus (HCV), lower post-treatment α-fetoprotein (AFP) levels and HCV genotype 2 correlate with liver fibrosis regression after sustained virological response (SVR), according ...

Life expectancy among patients with chronic hepatitis C virus infection and cirrhosis

November 11, 2014
Patients with chronic hepatitis C virus infection and advanced fibrosis or cirrhosis who attained sustained virological response (SVR) had survival comparable with that of the general population, whereas patients who did ...

Sustained virological response linked with improved survival for patients with chronic HCV infection

December 25, 2012
Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with ...

Statin use found beneficial in hepatitis C treatment

April 10, 2015
(HealthDay)—For patients with hepatitis C virus (HCV), statin therapy is associated with improved virologic response rates, as well as decreased liver fibrosis progression and hepatocellular carcinoma (HCC) incidence, according ...

SVR rates up with new regimens for HCV and HIV coinfection

February 24, 2015
(HealthDay)—For patients with hepatitis C virus (HCV) genotype 1 and HIV coinfection, new regimens are effective and correlate with high rates of sustained virologic response (SVR) after treatment, according to two studies ...

Recommended for you

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

Faecal transplants, 'robotic guts' and the fight against deadly gut bugs

December 13, 2018
A simple compound found in our gut could help to stop dangerous bacteria behind severe, and sometimes fatal, hospital infections.

Taking the virus out of a mosquito's bite

December 12, 2018
They approach with the telltale sign—a high-pitched whine. It's a warning that you are a mosquito's next meal. But that mosquito might carry a virus, and now the virus is in you. Now, with the help of state-of-the-art technology, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.